10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $930 | -16.7% | 22,536 | +12.7% | 0.01% | -11.1% |
| Q2 2023 | $1,117 | +6.1% | 19,998 | +6.0% | 0.01% | 0.0% |
| Q1 2023 | $1,053 | +38.9% | 18,870 | -9.2% | 0.01% | +28.6% |
| Q4 2022 | $758 | -99.9% | 20,790 | +1.7% | 0.01% | +16.7% |
| Q3 2022 | $582,000 | -35.4% | 20,448 | +2.7% | 0.01% | -25.0% |
| Q2 2022 | $901,000 | -39.4% | 19,913 | +1.9% | 0.01% | -33.3% |
| Q1 2022 | $1,487,000 | -72.2% | 19,551 | -45.5% | 0.01% | -40.0% |
| Q4 2021 | $5,348,000 | +133.9% | 35,898 | +128.6% | 0.02% | +5.3% |
| Q3 2021 | $2,286,000 | -29.8% | 15,705 | -5.6% | 0.02% | -26.9% |
| Q2 2021 | $3,256,000 | +69.2% | 16,628 | +56.4% | 0.03% | -63.9% |
| Q1 2021 | $1,924,000 | +17.0% | 10,630 | -8.5% | 0.07% | +16.1% |
| Q4 2020 | $1,645,000 | +13.6% | 11,615 | -0.0% | 0.06% | -1.6% |
| Q3 2020 | $1,448,000 | +43.7% | 11,617 | +2.9% | 0.06% | +34.0% |
| Q2 2020 | $1,008,000 | – | 11,286 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |